Financial results - ADYROM PHARM SRL

Financial Summary - Adyrom Pharm Srl
Unique identification code: 17046665
Registration number: J22/2791/2004
Nace: 4619
Sales - Ron
87.390
Net Profit - Ron
3.169
Employee
The most important financial indicators for the company Adyrom Pharm Srl - Unique Identification Number 17046665: sales in 2021 was 87.390 euro, registering a net profit of 3.169 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Intermedieri in comertul cu produse diverse having the NACE code 4619.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Adyrom Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 41.591 12.611 61.485 90.937 64.940 87.123 85.561 87.385 - -
Total Income - EUR 41.593 12.612 61.485 90.937 64.940 87.123 85.561 87.385 - -
Total Expenses - EUR 40.669 12.000 54.685 82.738 54.040 78.178 79.131 81.594 - -
Gross Profit/Loss - EUR 923 611 6.800 8.198 10.900 8.945 6.430 5.790 - -
Net Profit/Loss - EUR 772 484 4.422 5.470 8.952 6.331 3.863 3.169 - -
Employees 0 0 0 0 0 0 0 0 - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 4.4%, from 85.561 euro in the year 2020, to 87.385 euro in 2021. The Net Profit decreased by -608 euro, from 3.863 euro in 2020, to 3.169 in the last year.

Check the financial reports for the company - Adyrom Pharm Srl

Rating financiar

Financial Rating -
Adyrom Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Adyrom Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Adyrom Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Adyrom Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Adyrom Pharm Srl - CUI 17046665

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 29.561 27.067 24.670 40.984 - -
Current Assets 21.518 12.153 8.181 12.549 8.449 9.420 16.551 11.507 - -
Inventories 14.543 7.518 6.270 6.885 4.611 3.338 2.153 2.897 - -
Receivables 6.340 3.925 544 2.852 2.368 2.623 9.964 6.504 - -
Cash 636 710 1.367 2.812 1.471 3.459 4.434 2.106 - -
Shareholders Funds -1.339 -866 3.564 8.974 17.761 23.749 27.162 29.728 - -
Social Capital 45 45 45 44 43 42 41 40 - -
Debts 22.858 13.019 4.617 3.575 20.248 12.738 14.059 22.763 - -
Income in Advance 0 0 0 0 0 0 0 0 - -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.507 euro in 2021 which includes Inventories of 2.897 euro, Receivables of 6.504 euro and cash availability of 2.106 euro.
The company's Equity was valued at 29.728 euro, while total Liabilities amounted to 22.763 euro. Equity increased by 3.169 euro, from 27.162 euro in 2020, to 29.728 in 2021.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Adyrom Pharm Srl

Comments - Adyrom Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.